NHS Trust admits liability in long-running chemotherapy scandal

Prof Ian Brown's patients were told that treatment was lifesaving but UHCW later confirmed it was neither evidence-based nor aligned with NICE guidance.
Talk to us: 0333 004 4488 | hello@brabners.com | Contact us

Prof Ian Brown's patients were told that treatment was lifesaving but UHCW later confirmed it was neither evidence-based nor aligned with NICE guidance.

Despite guidelines recommending a maximum of six chemotherapy cycles, Lucy was prescribed over 75 across seven years — long after her scans showed no evidence of progression.

Across the UK, neurosurgery and neuro-oncology services at several NHS Trusts have been subject to independent reviews, regulatory scrutiny and (in some cases) Police investigations.

Prolonged chemotherapy treatment at University Hospitals Coventry and Warwickshire has sadly had a devastating and irreversible impact on David's life.

Concerns about chemotherapy now point to systemic failings involving neuro-oncology clinicians, neurosurgeons, neuroradiologists and more at UHCW.

Patients affected by the extended use of adjuvant Temozolomide chemotherapy have received a letter from University Hospitals Coventry and Warwickshire NHS Trust.

We’re the only solicitors to have been working with patients affected by Prof Ian Brown's long-term Temozolomide chemotherapy treatments since April 2024.

Recent revelations have raised concerns about patients who were subjected to prolonged temozolomide chemotherapy treatments at the University Hospitals of Coventry and Warwickshire NHS Foundation Trust.

Our team details what went wrong and how we went about securing compensation.

Our medical negligence team provided pro-bono legal support to the family of a young man who was considered brain-dead.